title: Spanish co-operative group of Medical Neuro-oncology (GENOM).
authors.forename: Jorge
authors.initials: J
authors.lastname: Contreras Martínez
authors.forename: José María
authors.initials: JM
authors.lastname: Azcoaga Blasco
authors.forename: Raquel
authors.initials: R
authors.lastname: Delgado Rico
authors.forename: Amadeo
authors.initials: A
authors.lastname: Wals Zurita
authors.forename: Asunción
authors.initials: A
authors.lastname: Villanueva Alvarez
authors.forename: Daniel
authors.initials: D
authors.lastname: Rivas Sánchez
authors.forename: Ismael
authors.initials: I
authors.lastname: Herruzo Cabrera
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology; D009462:Neurology; D012955:Societies, Medical; D013030:Spain; D000077204:Temozolomide; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide